Gene methylation: While the association of LOY and KDM5D loss discussed above links sex-specific gene methylation patterns to impaired anti-tumor immunity in men, KDM6A is another epigenetic modifier with likely strong influences in bladder cancer susceptibility by sex. This evidence concerns the gene KDM6A and urinary bladder carcinoma.